Overview of transplant mycology
Author:
Open Access
- 15 April 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 62 (suppl_1) , S17-S21
Abstract
Purpose. The epidemiology, clinical manifestation, diagnosis, and management of invasive mycoses in transplant patients are described. Summary. The incidence of and mortality from invasive mycoses have increased in transplant patients. Candida and Aspergillus are the two most common fungal pathogens in this patient population. The use of immunosuppressive and myeloablative therapies and other factors increases the risk of invasive mycoses. A high index of suspicion and clinical clues are needed for the diagnosis of Candida and Aspergillus infections because reliable diagnostic techniques are not available and the patient presentation is nonspecific. Targeted prophylaxis for patients at high risk for morbidity and mortality and early, aggressive treatment using broad-spectrum antifungal agents are recommended. Prophylaxis using itraconazole reduces the risk of treatment failure due to resistant pathogens compared with fluconazole. Voriconazole might prove advantageous compared with fluconazole and itraconazole for prophylaxis because of its extended spectrum and predictable blood levels. Caspofungin seems as effective as and less toxic than amphotericin B for this use. Voriconazole is more effective than amphotericin B for the treatment of aspergillosis. Caspofungin is comparable to voriconazole in efficacy as salvage treatment after failure to respond to other antifungal agents. Conclusion. Caspofungin plus voriconazole and other combination therapies often are used for the treatment of aspergillosis yet data to support such use are yet to be produced. The investigational agents posaconazole, micafungin, and anidulafungin appear promising as salvage treatment of various invasive mycoses.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- Systemic candidiasis in intensive care units: A multicenter, matched-cohort studyJournal of Critical Care, 2002
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997Clinical Infectious Diseases, 2001
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Invasive Aspergillosis Disease Spectrum, Treatment Practices, and OutcomesMedicine, 2000
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000
- RECENT PROGRESS AND CURRENT PROBLEMS IN TREATMENT OF INVASIVE FUNGAL INFECTIONS IN NEUTROPENIC PATIENTSInfectious Disease Clinics of North America, 1996
- Clinical Aspects of Fungal Infection in Organ Transplant RecipientsClinical Infectious Diseases, 1994
- Infections after Liver TransplantationMedicine, 1988